A PHASE I OPEN-LABEL STUDY OF THE SAFETY AND EFFICACY OF APATINIB (RIVOCERANIB) ADMINISTERED TO PATIENTS WITH ADVANCED MALIGNANCIES TO IMPROVE SENSITIVITY TO PEMBROLIZUMAB IN THE SECOND- OR LATER-LINE SETTING (APPEASE)

A phase I open-label study of the safety and efficacy of apatinib (rivoceranib) administered to patients with advanced malignancies to improve sensitivity to pembrolizumab in the second- or later-line setting (APPEASE)

Abstract Objective APPEASE is a phase I study to assess the safety, dosing, and efficacy of rivoceranib (a selective, small-molecule inhibitor of VEGFR2) in combination with pembrolizumab.We aimed to treat patients with metastatic malignancies who have progressed through at least first-line therapy, with pembrolizumab 200 mg every 3 weeks, as well

read more

DIAGNOSTICS OF INNOVATIVE DEVELOPMENT OF ENTERPRISES IN KYIV CITY

The article substantiates the need to diagnose the state of innovative development of enterprises in Kyiv.It is determined that the solution to the problems of destabilization of enterprises is seen primarily in the formation of a system of conceptual foundations for ensuring innovative development and its diagnostics.The prerequisites for diagnosi

read more


Laparoscopic subtotal cholecystectomy for difficult cases of acute cholecystitis: a simple technique using barbed sutures

Abstract Background Laparoscopic cholecystectomy (LC) for difficult acute cholecystitis (AC) cases bears a high risk of vasculobiliary injuries (VBI).The Tokyo Guidelines 2018 (TG18) recommend the use of bailout procedures and subtotal cholecystectomy to prevent VBI.Performing a safe LC is challenging, even when followed by an accurate pre-surgical

read more